STAAR Surgical Company (Form: 8-K)  

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   March 6, 2008

STAAR Surgical Company
__________________________________________
(Exact name of registrant as specified in its charter)

     
Delaware 0-11634 95-3797439
_____________________
(State or other jurisdiction 		_____________
(Commission 		______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
1911 Walker Ave, Monrovia, California   91016
_________________________________
(Address of principal executive offices) 		  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   626-303-7902

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Top of the Form

Item 2.02 Results of Operations and Financial Condition.

On March 6, 2008, STAAR Surgical Company (the "Company") issued a press release announcing its financial results for the quarter ended and fiscal year ended December 28, 2007. A copy of the press release is attached as Exhibit 99.1 to this Report and is incorporated herein by this reference.

The press release states that "During the fourth quarter . . . we announced the completion of the acquisition of all other shareholders’ interests in our Japanese joint venture, Canon Staar Co., Inc." The Company notes that the acquisition of those interests was actually announced in the first quarter of fiscal year 2008, on January 4, 2008, and that the closing of the transaction on December 29, 2007 also took place in the Company’s 2008 fiscal year.





Item 7.01 Regulation FD Disclosure.

On March 6, 2007 the Company held a conference call to discuss the financial results for the quarter and fiscal year ended December 28, 2007. An archive of the webcast of the conference call has been posted on the Company's website at www.staar.com. A transcript of the conference call is furnished as Exhibit 99.2 to this report and is incorporated herein by this reference.





Top of the Form

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    STAAR Surgical Company
          
March 12, 2008   By:   /s/Deborah Andrews
       
        Name: Deborah Andrews
        Title: Vice President, Chief Financial Officer

Top of the Form

Exhibit Index


     
Exhibit No.   Description
 
99.1
  Press release of the Company published march 6, 2008.
99.2
  Transcript of conference call held March 6, 2008.